1. MARKETS
  2. SECTOR : DIVERSIFIED CONSUMER SERVICES
  3. INDUSTRY : HEALTHCARE SERVICES
  4. FINCH THERAPEUTICS GROUP INC

Finch Therapeutics Group Inc

XNAS: FNCH

Download real time

13.70 0.00 (0.00%)

1612.50% Gain from 52W Low

1,027 XNAS Volume

XNAS 20 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
9S
7W
0O
0T
22

Market Cap

Low in industry
-1.6

PE TTM

Negative PE TTM
0

PEG TTM

1.5

Price to Book

Below industry Median
0.9

Beta 1Year

Low volatility
Board Meeting
The next board meeting for Finch Therapeutics Group Inc is on 25 Mar 2025 for the purpose of Finch Therapeutics Group Inc Annual Report for 2024 See details


Insider Trading disclosures for Finch Therapeutics Group Inc

The latest disclosure was made by Jeffrey A. Smisek in Finch Therapeutics Group Inc where a trade of 383 Common Stock done was reported to US exchanges on June 7, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Jeffrey A. Smisek Director Gift of securities by or to the insider at price $ 0.00 per share. 07 Jun 2024 383 24,383 - 0 Common Stock
Jeffrey A. Smisek Director Gift of securities by or to the insider at price $ 0.00 per share. 07 Jun 2024 384 17,870 - 0 Common Stock
Jeffrey A. Smisek Director Gift of securities by or to the insider at price $ 0.00 per share. 20 May 2024 3,750 0 - 0 Common Stock
Jeffrey A. Smisek Director Sale of securities on an exchange or to another person at price $ 2.61 per share. 28 Mar 2024 1,600 6,512 - 2.6 4,176 Common Stock
Jeffrey A. Smisek Director Sale of securities on an exchange or to another person at price $ 2.57 per share. 28 Mar 2024 6,642 0 - 2.6 17,070 Common Stock
Matthew P. Blischak Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 962,899 962,899 - - Stock Option (right to buy)
Chris Shumway Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 10,000 10,000 - - Stock Option (right to buy)
Jeffrey A. Smisek Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 10,000 10,000 - - Stock Option (right to buy)
Marc Blaustein Chief Operating Officer Sale of securities on an exchange or to another person at price $ 0.38 per share. 21 Feb 2023 4,619 27,995 - 0.4 1,755 Common Stock
Joseph Vittiglio Chief Business & Legal Officer Sale of securities on an exchange or to another person at price $ 1.39 per share. 21 Oct 2022 3,636 31,364 - 1.4 5,054 Common Stock
Marc Blaustein Chief Operating Officer Sale of securities on an exchange or to another person at price $ 1.39 per share. 21 Oct 2022 3,636 32,614 - 1.4 5,054 Common Stock
Marc Blaustein Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2022 35,000 36,250 - 0 Common Stock
Christian Lange Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2022 44,843 44,843 - - Stock Option (right to buy)
Nicholas Haft Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2022 44,843 44,843 - - Stock Option (right to buy)
Chris Shumway Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2022 44,843 44,843 - - Stock Option (right to buy)
Joanne Viney Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2022 44,843 44,843 - - Stock Option (right to buy)
Samuel Allen Hamood Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2022 44,843 44,843 - - Stock Option (right to buy)
Susan E. Graf Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2022 44,843 44,843 - - Stock Option (right to buy)
Joseph Vittiglio Chief Business & Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2022 35,000 35,000 - 0 Common Stock
Jeffrey A. Smisek Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2022 44,843 44,843 - - Stock Option (right to buy)
Joseph Vittiglio Chief Business & Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2022 75,000 75,000 - - Employee Stock Option (right to buy)
Gregory D. Perry Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2022 80,000 80,000 - - Employee Stock Option (right to buy)
Marc Blaustein Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2022 38,000 38,000 - - Employee Stock Option (right to buy)
Nicholas Haft Director Purchase of securities on an exchange or from another person at price $ 10.18 per share. 20 Dec 2021 63,850 4,056,907 - 10.2 649,993 Common Stock, $0.001 par value per share
Joseph Vittiglio Chief Business & Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Dec 2021 125,000 125,000 - - Employee Stock Option (right to buy)
Samuel Allen Hamood Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2021 25,543 25,543 - - Stock Option (right to buy)
Marc Blaustein Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Sep 2021 150,000 150,000 - - Employee Stock Option (right to buy)
Joanne Viney Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2021 23,419 23,419 - - Stock Option (right to buy)
Susan E. Graf Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Apr 2021 23,419 23,419 - - Stock Option (right to buy)
Nicholas Haft Director 23 Mar 2021 172,942 172,942 - - Common Stock
Jeffery A. Smisek Director 23 Mar 2021 272,245 1,606,306 - - Common Stock
Jeffery A. Smisek Director 23 Mar 2021 297,178 1,334,061 - - Common Stock
Jeffery A. Smisek Director 23 Mar 2021 894,955 894,955 - - Common Stock
Jeffery A. Smisek Director 23 Mar 2021 141,928 1,036,883 - - Common Stock
Jeffery A. Smisek Director 23 Mar 2021 272,245 0 - - Series D Preferred Stock
Jeffery A. Smisek Director 23 Mar 2021 297,178 0 - - Series C Preferred Stock
Jeffery A. Smisek Director 23 Mar 2021 141,928 0 - - Series B Preferred Stock
Jeffery A. Smisek Director 23 Mar 2021 894,955 0 - - Series A Preferred Stock
Jeffery A. Smisek Director Purchase of securities on an exchange or from another person at price $ 17.00 per share. 23 Mar 2021 88,235 1,694,541 - 17 1,499,995 Common Stock
Nicholas Haft Director 23 Mar 2021 1,150,481 0 - - Series D Preferred Stock
Nicholas Haft Director 23 Mar 2021 143,831 0 - - Series A Preferred Stock
Nicholas Haft Director 23 Mar 2021 143,831 143,831 - - Common Stock
Nicholas Haft Director 23 Mar 2021 1,064,466 1,064,466 - - Common Stock
Nicholas Haft Director 23 Mar 2021 366,093 1,430,559 - - Common Stock
Nicholas Haft Director 23 Mar 2021 212,893 212,893 - - Common Stock
Nicholas Haft Director 23 Mar 2021 1,150,481 1,150,481 - - Common Stock
Nicholas Haft Director Purchase of securities on an exchange or from another person at price $ 17.00 per share. 23 Mar 2021 882,351 882,351 - 17 14,999,967 Common Stock
Nicholas Haft Director 23 Mar 2021 172,942 0 - - Series A Preferred Stock
Nicholas Haft Director 23 Mar 2021 212,893 0 - - Series C Preferred Stock
Nicholas Haft Director 23 Mar 2021 366,093 0 - - Series C Preferred Stock
Nicholas Haft Director 23 Mar 2021 1,064,466 0 - - Series B Preferred Stock
Zain Kassam Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Mar 2021 69,232 69,232 - - Employee Stock Option (right to buy)
Mark Smith Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Mar 2021 595,402 595,402 - - Employee Stock Option (right to buy)
Joseph Vittiglio General Counsel and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Mar 2021 60,578 60,578 - - Employee Stock Option (right to buy)
Joseph Vittiglio General Counsel and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Mar 2021 34,616 34,616 - - Employee Stock Option (right to buy)
Gregory D. Perry Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Mar 2021 55,386 55,386 - - Employee Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters